Nutritional supplement for liver protection in hepatitis C
Part of Digestive system, Infections clinical trials.
This trial tests whether a special nutritional supplement can protect the liver in people with chronic hepatitis C. If you have mild to moderate liver damage and meet the criteria, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver disease from a chronic hepatitis C infection and are being seen at the Hepatitis Clinic at Hospital Civil Fray Antonio Alcalde.
- Your Child-Pugh score (a measure of liver function) is less than 8.
- You are between 18 and 69 years old.
- You have not had any alcohol in the past 6 months.
- You do not have serious liver complications (like severe fluid buildup, confusion, or kidney problems) and no history of cancer, autoimmune disease, or dementia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the drug rosuvastatin, a cholesterol-lowering medicine, can improve liver health in people with cirrhosis. If you have compensated cirrhosis (no recent serious liver problems), you might be able to join.
This trial tests a new treatment called HepaCure for people with acute-on-chronic liver failure (a sudden worsening of liver function in someone with long-term liver disease). The goal is to see if it is safe and can help improve liver function.
This study tests whether a herbal supplement can improve liver function in people with alcoholic liver disease. If you have liver damage from alcohol but not severe cirrhosis, this supplement may help your liver recover.
This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.
This study looks at how nutrition affects the health of people with liver cirrhosis (scarred liver) and aims to build a tool to predict their outcomes. If you have cirrhosis, joining may help researchers find better ways to support your health.
This trial tests a new medicine called larsucosterol to see if it helps people with severe alcohol-related hepatitis (liver inflammation from heavy drinking). If you qualify, the study will monitor your safety and recovery over 90 days.
Hear when a new HEPATITIS C VIRUS CHRONIC INFECTION trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.